A biosimilar is a biological medicine highly similar to another, already approved medicine. Physicians should be aware of definition, approval process, and biochemical and clinical features that distinguish biosimilars from the reference product.
Immunosuppressive therapy must be guided by therapeutic drug monitoring (TDM) in paediatric liver (LT) and kidney transplantation (KT) patients to prevent under- and overdosing, which have clinical consequences.
If drug therapy for secondary hyperparathyroidism (sHPTH) fails, total parathyroidectomy with autotransplantation of parathyroid tissue into the forearm (PTX-AT) is the most widely used procedure, but high recurrence rates are reported.
Erectile dysfunction (ED) has recently been identified as a predictor of generalised vascular disease and, besides the functional sexual impairment, symptoms of ED may be indicative of underlying risk factors or cardiovascular comorbidities.
Recurrent glioblastoma (GBM) is a disease with poor prognosis for which there is no established standard therapy. A recent survey among Swiss neuro-oncology centres has shown considerable differences in treatment recommendations.
SMW is an international peer-reviewed medical journal, established in 1871 following the Public Service Open Access model (also known as Diamond or Platinum Open Access).
E-mail alerts -- Linkedin -- Twitter -- RSS
e-mail: Editorial office
EMH Media - Schweizerische Ärztezeitung - Swiss Medical Forum - Primary and Hospital Care - Cardiovascular Medicine - Swiss Archives of Neurology, Psychiatry and Psychotherapy - Synapse - Swiss Medical Informatics